Enorama Pharma AB
Research Enorama Pharma AB (ERMA) on Bullrun: market cap SEK 50.12M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerERMA
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencySEK
- Market capSEK 50.12M
- Financial periodQ1 2026
- Revenue-SEK 109.00K
- Net income-SEK 12.65M
- Free cash flow-SEK 12.09M
- Gross margin46.8%
Valuation Snapshot
latest market cap is SEK 50.12M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 2.74M | -SEK 75.14M | -SEK 60.08M | -549.2% | -1.11 | SEK 3.04M | SEK 0 | -SEK 23.45M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-28 | SEK 50.12M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Enorama Pharma AB
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Enorama Pharma AB's market cap?
Enorama Pharma AB's market capitalization is SEK 50.12M.
What does Enorama Pharma AB do?
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.